JOURNAL DESCRIPTION
The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.
Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.
Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.
The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.
Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.
The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.
Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.
The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.
Medical Radiology and Radiation Safety. 2017. Vol. 62. No. 6. P. 21-27
DOI: 10.12737/article_5a25317ce480f3.74497732
RADIATION BIOLOGY
Comparison of the Combined Effects of Hyperthermia with Ionizing Radiation or Cisplatin on Yeast and Mammalian Cells
M.D. Pronkevich1, E.S. Evstratova1, S.V. Belkina1, Yu.N. Anokhin1,2, V.G. Petin1
1. A.F. Tsyb Medical Radiological Research Center, Obninsk, Russia, email: This email address is being protected from spambots. You need JavaScript enabled to view it. ; 2. Obninsk Institute of Atomic Energy, Obninsk, Russia
M.D. Pronkevich – PhD Biol., Senior Researcher; E.S. Evstartova – PhD Biol., Researcher; S.V. Belkina – PhD Biol. Senior Researcher; Yu.N. Anokhin – Head of Med. Phys. Dep., Obninsk Institute for Nuclear Power Engineering, PhD Med.; V.G. Petin – Head of Biophys. Lab., Dr. Sc. Biol., Prof., Member of Editorial Board of Korean Journal of Environmental Biology
Abstract
Purpose: To compare radiation responses of yeast and mammalian cells to combined actions of various agents and on this basis to draw a conclusion about the possibility of synergy ideas application in medical radiology.
Material and methods: The yeast cells of Saccharomyces cerevisiae were exposed to the combined action of hyperthermia (22–58 °Ϭ exposure time 0–9 hrs) with ionizing radiation (25 MeV bremsstrahlung 5 and 25 Gy/min or γ-rays 60Ү, 2, 10, and 80 Gy/min, acute irradiation) or anti-tumor drug cisplatin (0.05 or 0.25 mg/ml, exposure time 0–3 hrs). The result of synergistic interaction for yeast cells was assessed by the survival curves obtained by the authors after separate exposure to hyperthermia, ionizing radiation, cisplatin and after combined action of hyperthermia with ionizing radiation or cisplatin. To quantify the synergistic interaction of similar combined actions on mammalian cells, the data published by other authors have been used who did not evaluate the synergistic effect themselves.
Results: The synergistic interaction of hyperthermia with ionizing radiation or cisplatin was established for yeast and mammalian cells. It is shown that the synergistic effect of the simultaneous action of these agents is observed only within a certain temperature range, within which there is an optimal temperature at which the greatest synergism occurs. This optimal temperature is shifted to lower values with a decrease in the dose rate of ionizing radiation or concentration of cisplatin. For sequential application of hyperthermia and ionizing radiation the effect of combined action increases with an increase in acting temperature up to a certain limit, after which it remains constant. These results are interpreted using the mathematical models previously proposed, in accordance with which the synergism is determined by the formation of additional damage due to the interaction of sub-damage that are not effective after separate application of agents.
Despite the fact that all of the data presented were obtained at temperatures far beyond the ambient temperature, it is not excluded that there could be optimal intensities of harmful agents existing in the biosphere and capable of interacting with physiological heat of animals and man in a synergistic manner. Hence, the assessment of health or environmental risks from numerous natural and man-made agents at the level of intensities found in environmental and occupational settings should take into account synergistic interaction between harmful agents.
Conclusion: The general regularities of synergistic effects of combined action of hyperthermia with ionizing radiation or with cisplatin for yeast and mammalian cells have been established – the existence of optimal parameters for acting agents providing the highest synergy and its dependence on the intensity of agents applied.
Key words: ionizing radiation, hyperthermia, cysplatin, combined actions, synergism, optimization, yeast, mammalian cells
REFERENCES
- Kuzin A.M., Kaushanskiy D.A. Prikladnaya radiobiologiya. Teoreticheskiye i t ekhnicheskiye osnovy. Moscow: Energoizdat. 1981. 222 p. (In Russ.).
- Yarmonenko S.P., Konoplyanikov A.G., Vaynson A.A. Klinicheskaya radiobiologiya. Moscow: Meditsina. 1992. 320 p. (In Russ.).
- Hall E.J., Giaccia A.J. Radiobiology for the Radiologist. Lippincott: Williams and Wilkins. 2011. 576 p.
- Kurpeshev O.K., Mardynskiy Yu.S. Radiomodifikatory v luchevoy terapii opukholey. V kn.: «Terapevticheskaya radiologiya. Rukovodstvo dlya vrachey». Pod red. A.F. Tsyba. Yu.S. Mardynskogo. Moscow: OOO «MK». 2010. P. 13–26. (In Russ.).
- Streffer C., Vauper P., Hahn G. Biological Basis of Oncologic Thermotherapy. Berlin. Heidelberg. New York. London. Paris. Tokyo. Hong Kong: Springer Verlag. 1990. 169 p.
- Sugahara T., Saito M. (eds.) Hyperthermic Oncology. vol. I. London: Taylor & Francis. 1988. vol. II. London: Taylor & Francis. 1989. 950 p.
- Tsyb A.F., Gulidov I.A. Sovremennoye sostoyaniye luchevoy terapii zlokachestvennykh novoobrazovaniy. V kn.: «Terapevticheskaya radiologiya. Rukovodstvo dlya vrachey». Pod red. A.F. Tsyba. Yu.S. Mardynskogo. Moscow: LLC «MK». 2010. P. 7–12. (In Russ.).
- Kuzin A.M. Problema sinergizma v radiobiologii. Izvestiya AN SSSR. Seriya biologicheskaya. 1983. No. 4. P. 485–502. (In Russ.).
- Zhurakovskaya G.P. Obshchiye zakonomernosti i prognozirovaniye sinergicheskogo vzaimodeystviya faktorov okruzhayushchey sredy. Obninsk: Diss. dokt. biol. nauk. 2001. 314 p. (In Russ.).
- Petin V.G., Zhurakovskaya G.P., Komarova L.N. Radiobiologicheskiye osnovy sinergicheskogo vzaimodeystviya v biosfere. Moscow: GEOS. 2012. 219 p. (In Russ.).
- Petin V.G., Kim J.K. Synergistic Interaction and Cell Responses to Environmental Factors. New York: Nova Sciences Publisher. 2016. 337 p.
- Ben-Hur E. Mechanisms of the synergistic interaction between hyperthermia and radiation in cultured mammalian cells. J. Radiat. Res. 1976. Vol. 17. No. 2. P. 92–98.
- Ben-Hur E., Elkind M.M. Thermally enhanced radioresponse of cultured Chinese hamster cells: damage and repair of single–stranded DNA and a DNA complex. Radiat. Res. 1974. Vol. 59. No. 2. P. 484–495.
- Dewey W.C., Holahan E.V. Hyperthermia – basic biology. Prog. Exp. Tumor Res. 1984. Vol. 28. P. 198–219.
- Urano M., Kahn J., Majima H. et al. The cytotoxic effect of cis-diamminedichloroplatinum(II) on cultured Chinese hamster ovary cells at elevated temperatures: Arrhenius plot analysis. Int. J. Hyperthermia. 1990. Vol. 6. No. 3. P. 581–590.
- Evstratova E.S. Sinergizm i vosstanovleniye kletok posle kombinirovannogo deystviya khimicheskikh agentov s ioniziruyushchim izlucheniyem ili gipertermiyey. Obninsk: diss. kand. biol. nauk. 2015. 121 p. (In Russ.).
For citation: Pronkevich MD, Evstratova ES, Belkina SV, Anokhin YuN, Petin VG. Comparison of the Combined Effects of Hyperthermia with Ionizing Radiation or Cisplatin on Yeast and Mammalian Cells. Medical Radiology and Radiation Safety. 2017;62(6):21-7. Russian. DOI: 10.12737/article_5a25317ce480f3.74497732
PDF (RUS) Full-text article (in Russian)